Kraemer WJ, Volek JS, French DN, Rubin MR, Sharman MJ, Gmez AL, Ratamess NA, Newton RU, Jemiolo B, Craig BW, Hkkinen K
Nutritionists and obesity medicine specialists generally acknowledge that compounded semaglutide, when sourced from an FDA-registered compounding pharmacy and prescribed by a licensed provider, may offer a pharmacologically equivalent effect to brand-name formulations, though it is important to note that compounded products have not undergone the same FDA approval process as brand-name drugs
Angiogenesis-related signaling in in-vitro pathway assays
The idea is that it strengthens the gut barrier and reduces inflammation at the source